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INTRODUCTION
Accelerated graft arteriosclerosis (AGAS) of the coronary
arteries remains a significant obstacle to the long-term sur-
vival of cardiac transplant. Recent studies documented the
incidence of AGAS up to 44% in 3 yr after transplantation
(1). Although the pathogenesis of AGAS has not been clear-
ly understood yet, there are evidences that it could be resul-
ted from an immunological insult to the coronary arteries
associated with histoincompatibilities between the donor
and recipient. It is generally believed that AGAS involves a
localized cell-mediated immune response initiated by acti-
vation of host T-lymphocytes by graft endothelial cells (2,
3). T-cell activation within the vessel wall would cause a
local production of cytokine or growth factors that result in
an accumulation and proliferation of smooth muscle cells in
the intima of graft arteries (4). In addition to the initiating
role of major histocompatibility complex (MHC) antigens,
inflammatory stimuli such as bacterial lipopoly-saccharide
(LPS), interferon- (IFN- ), interleukin-1 (IL-1 ), IL-1 ,
and tumor necrosis factor- (TNF- ) that are secreted by
activated immune cells potently induce leukocyte adhesion
molecules to activate endothelial cells and to greatly increase
binding of lymphocytes and monocytes. Induction of proin-
flammatory genes by endothelial cells is often triggered by
proinflammatory cytokines such as TNF- and IL-1, and is
largely dependent on the activation of members of the Rel/
nuclear factor  B (NF- B) family of transcription factors (5).
The transcription factor NF- B is a critical regulator of
cytokine-inducible gene expression (6). NF- B is a pleiotro-
pic regulator of many genes involved in immune and inflam-
matory response including the cytokines, chemokines, grow-
th factors, cell adhesion molecules, immunoreceptors as well
as acute-phase proteins. In resting cells, NF- B resides in
an inactive cytosolic form through its interaction with the
members of a family of inhibitor proteins, like I B- , I B-
, I B- , or Bcl-3, known as inhibitory  B (I- B).
The present study was designed to investigate whether
these cytokines (IFN- , TNF- ) exert their positive effects
on the signalling of NF- B family members by identifying
interaction between cytokines and NF- B in regard to the
degree of expression and colocalization. For this, we investi-
gated the early time course of activated NF- B and cyto-
kines (IFN- , TNF- ) in the lesions of transplanted mouse
heart allograft tissues. The results provided a correlative
data between the temporal and spatial patterns of expres-
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Expression of NF- B and Cytokines in Chronic Rejection of 
Transplanted Murine Heart 
The heart transplantation-associated accelerated graft arteriosclerosis (AGAS)
is one of the major causes of cardiac allograft failure. We investigated the early
time-course of expresssion patterns of cytokines, transcription factor, and its
inhibitor in the intraabdominally transplanted mice hearts that differed only in the
D locus of class I histocompatibility antigen. The allograft hearts were harvested
at 1-3, 5, 7, 14, 28, and 42 days after the transplantation, and the expressions of
NF- B/I- B and cytokines (TNF- , INF- ) were examined in these specimens.
The expressions of TNF- and INF- were observed on day 1, peaking on day 5
and 7, respectively. Activated NF- B (p65) expression was present on the cyto-
plasm and perinuclear area in the endothelial cells of coronary arteries on day 1.
The peak of translocation of NF- B from cytoplasm to nucleus appeared on day
5 in the endothelial cells, myocytes, and leukocytes within the vessels, and
remained elevated until day 42. The I- B expression gradually increased from
day 1 until day 5, but a  remarkable decrease was detected on day 7. Our data
suggest that the increased expressions of NF- B/I- B and cytokines (TNF- ,
INF- ) play an important role in inducing immune responses in the donor allo-
graft heart and hence the blockage of the expressions might be mandatory to
avoid a potential graft failure. 
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sion of the NF- B/I- B regulatory system and two  B-
dependent cytokine gene products in the development of
AGAS lesion in the chronic rejection of transplanted murine
heart. In addition, we have demonstrated that this transcrip-
tion factor is important for the early responses of immune
cells (macrophage, lymphocyte) to an immunological insult
due to MHC disparity and for cytokine-inducible gene ex-
pression in endo-thelial cells of coronary arteries.
MATERIALS AND METHODS
Animal preparation
Adult mice (seven to ten weeks of age) of B10.A and
B10.BR strains, weighing 17-22 g, were obtained from
Jackson Laboratories (The Jackson Laboratory, Bar Harbor,
U.S.A.). The B10.A (H-2Dt
a) and B10.BR (H-2Dk) strains
differ only in the D locus of the class I MHC antigen.
B10.A mice were used as donors, and B10.BR mice were
used as recipients. The mice were housed under convention-
al conditions and fed a standard diet (Rodent laboratory
chows, Cheil Jedang Co., Incheon, Korea) and water ad libi-
tum. After completion of the heterotopic heart transplanta-
tion, the mice were allowed to recover with oxygen and
local heat, and then transferred into their cages after 24 hr
of surgery with a free access to food and water. Each of five
recipient mice were sacrificed at 1-3, 5, 7, 14, 28, and 42
days after transplantation.
Heterotopic Heart Transplantation
Intraabdomenal heterotopic heart transplantation was
performed with a modification of the technique described
by Corry et al. (7). Cardiac allograft from B10.A mice were
transplanted into B10.BR mice using standard microsurgi-
cal techniques. After anesthesia using 4% chloral hydrate
(0.1 mL/20 gm of body weight, intraperitoneal injection)
and methoxyflurane (inhalation), a “U”-shaped sternal lid
was made and lifted cephalad. Both the right and left supe-
rior caval veins were ligated with 5-0 silk. The donor heart
was arrested with cold heparinized saline (100 units/mL of
saline) delivered via the inferior caval veins. The aorta and
main pulmonary artery were then transected. After transec-
tion of caval veins distal to the ligatures, the pulmonary
veins were ligated en bloc and transected. The donor heart
was preserved in 4℃ cold saline solution until the recipient
mouse was prepared. Through a midline abdominal skin
incision, the recipient’s infrarenal abdominal aorta and infe-
rior caval vein were dissected and controlled both proximal-
ly and distally with 5-0 silk ligatures. After a longitudinal
aortic incision, an end-to-side anastomosis between the
transected ends of donor ascending aorta and the recipient
abdominal aorta, followed by an end-to-side anastomosis
between the transected ends of donor pulmonary artery and
the recipient inferior caval vein were performed using 10-0
nylon sutures. Subsequently, the proximal recipient aortic
ligature was released first.
Immunohistofluorescence Stain
Tissue specimens were fixed in neutral buffered formalin,
embedded in paraffin, and 4- m sections were placed on
glass slides. Paraffin embedded sections were deparaffinized
in xylene and hydrated through the standard graded ethanol.
Then the tissue was rehydrated in 0.1 M phosphate buffered
saline (PBS) for 5 min. Cell-bound antibodies were essen-
tially visualized using a sensitive immunohistochemical
technique. For blocking of non-specific binding, sections
were incubated in 15  g/mL of normal horse serum. The
sections were then incubated with the primary antibodies of
rat anti-mouse IFN- , rabbit anti-mouse TNF- , rabbit anti-
mouse p65 (Santa Cruz, U.S.A.), and I- B/MAD-3 (Santa
Cruz, U.S.A.), polyclonal antibody for two hours in a humi-
dified chamber at room temperature. The slides were dip-
ped in PBS in 0.1% Triton X-100 for three min in order to
reduce background noise and further washed additional
three times with PBS. Then the specimens were incubated
with FITC-labeled secondary antibodies (rabbit anti-rat IgG
antibodies, swine anti-rabbit IgG antibodies conjugated
with FITC (Dako, Denmark) for 30 min at room tempera-
ture in the dark. Following subsequent washes in PBS with
0.05% Tween-20, the slides were counterstained with pro-
pidium iodide/antifade (Oncor, U.S.A.), and mounted with
fluorescence mounting media (Dako, Denmark). Expression
of antigen was determined on endothelium of coronary
arteries, endocardium, and myocardium. The sections were
examined and scored on a scale of 0 to 3 by two investiga-
tors in a blind manner (Table 1). Photomicrographs were
taken with a fluorescence microscope (Olympus, Japan). All
arteries and arterioles larger than 50 mm in diameter were
examined and scored in at least 3 sections per graft.
Immunohistochemical Double-staining
On each corresponding day, five mice were sacrificed and
freshly dissected heart grafts were removed. Specimens were
serially sliced into 4- m thickness, and preserved in 10%
0 Negative 
1 Equivocal staining
2 Definite positive staining in intramyocardial arterioles 
3 Positive staining in myocytes and interstitium in addition 
to arterioles
Grade  Extent of immunofluorescent staining
Table 1. Grading scale of the semi-quantitative method in
measuring NF- B, I- B, TNF- , and INF- in cardiac tissuesExpression of NF- B and Cytokines in Transplanted Murine Heart 399
buffered formalin. Tissue specimens were fixed in buffered
formalin, embedded in paraffin, and 4- m sections thereof
were placed on glass slides. Paraffin embedded sections were
deparaffinized in xylene, hydrated through the standard
graded ethanol, and washed 3 times for 5 min each in PBS
(pH 7.5). Cell-bound antibodies were visualized using a
sensitive immunohistochemical technique. Cell membrane
was permeabilized by sequential treatment with 0.2% and
0.5% Triton X-100 in PBS for 10 min each. For blocking
of non-specific binding, sections were incubated in 15 g/
mL of normal horse serum. The sections were then incubat-
ed with the primary antibodies of rat anti-mouse IFN- ,
rabbit anti-mouse TNF- , rabbit anti-mouse p65 (Santa
Cruz, U.S.A.), polyclonal antibody, and mouse anti-mouse
H-2D antibody for 2 hr in a humidified chamber at room
temperature. After washing in 1×PBS, the specimens were
incubated with FITC-labeled secondary antibodies for rab-
bit anti-rat IgG antibodies and swine anti-rabbit IgG anti-
bodies (Dako, Denmark), and with CyTM 3-labeled secondary
antibody (Zymed Lab.) of goat anti-mouse IgG antibodies
for 1 hr at room temperature in the dark. After subsequent
washes in PBS with 0.05% Tween-20, the slides were coun-
terstained with nuclear DAPI and mounted with fluores-
cence mounting media (Dako, Denmark). Expression of
antigen was determined on endothelium of coronary arter-
ies, endocardium, and myocardium. Photomicrographs
were taken with a fluorescence microscope (Olympus, Japan).
Confocal Laser Microscopy
To detect the translocation of NF- B, immunohistofluo-
rescence technique was used with confocal laser microscope
(MRC 1024/UV, Biored, U.S.A.) (×600). Re-distribution
to the nucleus indicated the activation of transcription fac-
tor NF- B.
Western Blot Analysis
To determine the cytokine IFN- in serum samples of
the harvested mouse hearts after transplantation, Western
blot technique (Towbin et al. 1979; Burnette 1981) was
used. Sera diluted with DDW at 1:50 were denatured with
Laemmli sample buffer (2×SDS sample buffer) by boiling
for 3 min. For Western blot analysis, serum proteins were
separated on 10% SDS-PAGE and transferred to nitrocellu-
lose membrane filter at 100 voltage for 1 hr. Following pro-
tein transfer, the membrane was washed briefly with 1×
TBS. For blocking of non-specific antibody-antigen com-
plex formation, the membrane was immersed in 0.2% non-
fat dry milk dissolved in TTBS (150 mmol/L NaCl, 10
mmol/L Tris-HCl, 0.1% Tween 20, pH 7.4) for 1 hr and
subsequently shake-incubated for 1 hr at room temperature
with a 20  g/10 mL diluent of primary rat monoclonal
antibody against mouse IFN- (Pharmingen), followed by
washing for 3×5 min in washing buffer. Then the mem-
branes were incubated with alkaline phosphatase-conjugated
goat anti-rat IgG at 0.2  g/mL dilution of blocking buffer
for 1 hr. Immunoreactive bands were visualized using Wes-
tern-LightTM Chemiluminescent Detection System (CSPD
�
Chemiluminescent Substrate, TROPIX). Immunoreactive
bands were visualized using an enhance chemiluminescence
kit (Amersham). The membrane was further incubated for
5 min in CSPD Ready-to-Use substrate solution and finally
exposed to a film for 10-20 min immediately after the incu-
bation. Quantification was performed by densitometric
scanning of bands on the developed film with TINA-2.0
program using Fuji-film BAS (Biological Analyzing System)
-2500 read plate and a CCD camera.
Enzyme-linked immunosorbent assay (ELISA)
Plasma samples obtained by recipient mouse heart were
left for 30-60 min at room air, and were prepared by cen-
trifugation of whole blood at 3,000 rpm at 4℃ for 10 min.
The plasma samples for TNF- ELISA were sequentially
centrifuged at 10,000 rpm at 4℃ for 20 min to remove
platelets. The supernatants were transferred to fresh tubes
and immediately stored at -70℃ by deep freezer until use.
The samples were serially diluted at 1:50 with 0.1% swine
serum/PBS and incubated in ELISA modules (Nunc) coated
with anti-mouse/rat TNF- monoclonal antibody (Pharmin-
gen) at 4℃for 24 hr. After washing four times with PBS
containing 0.5% Tween 20 (PBS-T), rabbit anti-mouse
TNF- polyclonal antibody (Genzyme) was added as a detec-
tion antibody in ELISA modules, followed by incubation at
37℃ for 1 hr. Next, the modules were washed five times
with PBS-T and incubated with horseradish peroxidase-
conjugated anti-rabbit IgG (Vector Lab) for 1 hr at 37℃.
Finally, these ELISA modules were washed five times with
PBS-T, and a 30% hydrogen peroxide/ ABTS [2, 2′ -Azino-
bis-(3-ethylbenzthiazoline-6-sulfonic acid)] substrates were
added. The colorimetric reaction was allowed to run for 30
min and was stopped with 1N H2SO4. The resulting grada-
tions of yellow color were subtracted from each standard
sample. The concentration of TNF- in each well was deter-
mined by extrapolating the measured absorbance at 405 nm
on an ELISA reader (Dynatech Lab) to a standard curve.
Statistical Analysis
The mean±standard error values were calculated in each
group of mice. ANOVA with single factor analysis was used
to determine statistical significance.
RESULTS
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harvest. Cold ischemic time ranged from 40 to 61 min (mean
49±8 min).
Expression Pattern of Cytokines (TNF- IFN- ) in the
Allograft Tissue
IFN- expression in the cardiac allograft tissues was detec-
ted in the activated donor coronary arteries and epicardium
with a mean grade of 1.67±0.44 on day 1 after transplan-
tation. The intensity of expression increased gradually after
day 7, and remained unchanged thereafter. However, the
recipient’s tissues showed decreased IFN- expression except
a mild degree of elevation from day 5 to day 14 (Fig. 1B).
TNF- expression in the donor arteries was detected from
day 1 at a mean grade of 1.67±0.48, peaking on day 7, and
remained at a mean grade over 2.00 by day 42. By compari-
son, TNF- expression in the recipient heart remained at a
lower grade throughout the experiment (Fig. 1A).
Level of TNF- in mouse serum at each time after trans-
plantation were much higher than that in normal control
group (B10.BR) during the initial day 1-5 period and
thereafter decreased to a lower level than in control (Fig. 2A).
Level of IFN- from day 1 to day 7 in the graft mouse
serum was higher than in normal control group (B10.BR).
After day 14, the level of IFN- persistently remained
strong positive (Fig. 2B). In particular, the level of IFN-
and TNF- in early stage was distinctively higher in allo-
graft serum than in normal control group. The peak increas-
es in release of TNF- and IFN- were seen during day 1-5
and after day 14, respectively.
In addition, a time-dependent correlation between cyto-
kines (IFN- , TNF- ) and class I MHC expression was re-
vealed by immnunohistochemical procedure for sequential
double antigen staining in the donor allograft tissues (Fig. 4).
Fig. 4A and B shows a significant correlation in the local-
izations of TNF- and class I MHC expression in the epi-
cardium and arteries. Also, Fig. 4C and D shows a signifi-
cant correlation in the localizations of IFN- and class I
MHC in the myocardium and the immune cells within the
vessel on day 5.
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Fig. 1. The expression pattern of TNF- (A) and IFN- (B) in the
murine allograft tissue.
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Fig. 2. The serial changes of TNF- and IFN- in allograft serum
after transplant. (A) ELISA analysis of TNF- . (B) Western blot
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Fig. 3. Expression of activated cytokine (TNF- , IFN- ) in cardiac tissues. The TNF- and IFN- expressions are present minimally in
the recipient allograft vessel on day 3 (A, E), in the recipient allograft myocardium on day 5 (B, F), and was detected in the vicinity of
donor vessel on day 5 (C, G) and in the donor myocardium on day 7 (F, H). Greenish color represents positive staining (A×400, B-H
×200).
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Fig. 4. Colocalization of activated cytokines (TNF- , IFN- ) and
MHC antigen expressions in the allograft tissues. The green
FITC (arrows) indicates a positive expression of cytokines
TNF- (A, B, C) and IFN- (D, E). The red Cy3 fluorescence
(arrowheads) indicates a positive expression of MHC antigen.
Blue DAPI fluorescence is for the nucleus couterstain (×200).
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Fig. 5. The expression patterns of transcription factor NF- B
and I- B in the murine allograft tissues. (A) Temporal and spa-
tial patterns of expression of activated NF- B and (B) I- B in the
donor artery, myocyte, and lymphocyte after transplantation.
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Expression and Translocation of Activated NF- B in the
Lesion
To detect locational change of p65, a component of NF- B
whose transport is expressed after NF- B activation, in the
lesion, indirect immunofluorescence techniques with confo-
cal laser microscope were employed using the polyclonal
antibody against p65. Expression of p65 was not detectable
in normal heart of unmanipulated mice, but was detected
in endothelial cells and myocardium on day 1 after transplan-
tation. The pattern of location was cytoplasmic and perinu-
clear. In particular, our immunohistochemical studies  showed
a partial positive staining for p65 in the nucleus of cardiac
endothelial cell, and primarily of immune cells, which are
supposed to be the prime target cells for ischemic-reperfu-
sion injury after cardioplegic arrest and reperfusion. On day
3, the location of p65 expression began to change from cyto-
plasm to nucleus. The change was very little but detectable.
This translocation was observed more frequently in epi-
cardium and immune cell within the endocardium than
other site of cardiac tissues (Fig. 6B). These cells with
translocated p65 were increased from day 3, 5, 7. The peak
of translocation ratio and quantitative increase was observed
on day 7. However, p65 expression in peripheral blood cells
was peaked on day 5 and thereafter remained weakly positive
(Fig. 5A). The translocated p65 was predominantly found
in the nucleus of endothelial cells in coronary arteries, the
significant proportion of myocytes, and frequently in leuko-
cytes within a vessel (Fig. 6). Also, the translocation of p65
could be mostly detected in the immune cells (in particular,
macro-phages and a subset of T cells) within the donor ves-
sel in the AGAS (Fig. 6). On day 14, although the translo-
Fig. 6. Expression of activated transcription factor NF- B and I- B in the lesion. The expression of activated NF- B in the AGAS lesion
is localized in myocardium on day 1 (A), immune cells within the vessel on day 3 (B), epicardium on day 3 (C), coronary artery on day
5 (D), endothelium and adventitia on day 7 (E), and myocardium on day 7 (F) in an advanced AGAS. The I- B expression is localized
in the immune cells within the vessel on day 3 (G) and coronary artery on day 5 (H). The green fluorescence indicates activated NF- B
and I- B, which was shown by an indirect immunofluorescence method (×200, G and H ×400).
A
E
B
F
C
G
D
H
Fig. 7. Translocation of activated transcription factor NF- B from
cytoplasm into nucleus, which was detected by immunofluore-
scence technique confocal laser microscope. Arrows represent
the activated NF- B in the nucleus (×600).
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Fig. 8. Colocalization of activated transcription factor NF- B and MHC antigen in the allograft tissue. The green FITC (arrows) and the
red Cy3 fluorescence (arrowheads) indicates a positive expression of activated NF- B and MHC antigen, respectively. The blue DAPI
fluorescence counterstains the nucleus (×200).
cation of p65 from cytoplasm to nucleus was observed in
any sites, cytoplasmic expression was definitely detected.
Expression of p65 in nucleus after day 28 was predominant-
ly visualized along with the expression in cytoplasm by im-
munofluorescence staining, and this expression pattern re-
mained until day 42. NF- B protein acts as a transcription
factor and exerts its effects in the nucleus. Cytoplasmic reg-
ulatory mechanisms may modulate NF- B expression after
the translocation. Therefore, our immunohistochemical
findings of localization of NF- B protein in nuclei of endo-
thelial cells and cardiac myocytes may be considered im-
portant for the delineation of possible consequences of the
increased levels of the protein.
In addition, the present study has shown that coexpression
of p65 and class I MHC antigen was localized by immnuno-
histochemical procedure for sequential double antigen stain-
ing in the donor allograft tissues (Fig. 8). The location of
p65 and class I MHC antigen expression were excessively
relative to interaction in the epicardium and arteries (Fig.
8A). The striking similarity of colocalization of activated
NF- B with class I MHC antigen expression in the endo-
thelial cell indicates that NF- B is related to the gene ex-
pression in the development of AGAS lesion.
Expression of I- B (N-terminal)
There was no detectable expression of I- B in normal
heart from unmanipulated mice (B10. A) (Fig. 5). In contrast
to p65/p50 and p65 for NF- B, protein for I- B was found
in normal endothelium but the level varies from cell to cell.
Increased immunostaining for I B- is seen at the wound
edge at all late stages along with endothelial hyperplasia.
On day 1 after transplantation, there was a trace of expres-
sion of I- B in endothelial cells in coronary artery (CA),
which was similar to that in myocardium (M) and leuko-
cytes (L). On day 3, the increased expression of I- B was
found in all three locations (CA, M, and A). The highest
level of expression was detected in endothelial cells, and a
reaction signal in the nucleus of myocardium was shown
(Fig. 6H). The level of I- B expression was gradually increa-
sed on day 5 and 7 (Fig. 6G). However, a remarkable decrea-
se of the expression was detected on day 7 (Fig. 5B).404 J.R. Lee, C.J. Seok, J.S. Kim, et al.
DISCUSSION
This study demonstrated the time-course of expressions
of transcription factor NF- B and cytokines (INF- , TNF- )
in donor coronary arteries and myocardium in the murine
cardiac transplant model with AGAS, and showed the piv-
otal effects of NF- B and cytokines on the development of
AGAS. We used the mice strains with a minor MHC anti-
gen disparity. The strains (B10.A/B10.BR) differ in the D
locus of class I MHC antigen and previously reported as the
strain pair with long-term donor heart survival (8, 9) and
progressive intimal thickening of coronary arteries (10).
Presumably, subclinically sustained immunological insult
to the coronary arteries due to the MHC antigen differences
between the donor and recipient ultimately results in the
development of AGAS (11, 12). Also, previous study con-
firmed that the incidence of severe post-transplant coronary
artery disease in this strain combination was 60% during
the 50 postoperative days, which was similar as that in the
human cardiac graft arteriosclerosis. In addition, the patho-
logic features of the lesions were similar to those observed
in the human cardiac recipients after long survival, which
consist mainly of vascular smooth cell growth and limited
inflammatory cell infiltrations primarily of macrophages
(13, 14). Despite the observation of chronic vascular rejec-
tion by numerous investigators, little is known about the
early time-dependent course of the immunological events
including immune cell infiltration, cytokines levels, and
MHC antigens. However, it is clear that either class I or class
II alloantigens plays an important role as an inducer of the
rejection of vascularized heart allograft even though MHC
disparity is not consistently related to the kinetics or rate of
graft rejection and the patterns of MHC expression among
strains. Our previous studies have shown that the class I
MHC antigen (H-2D) expression of the donor tissues (endo-
thelial and medial cells of coronary arteries) was highest on
the 7th post-transplant day and then remained elevated,
whereas that in the recipient tissues was only partly present
on infiltrating monocytes. Moreover, class II MHC antigen
was not detected at any point of time (15). The upregulation
of class I MHC antigen activity by MHC disparity may sti-
mulate T cell immune activity and subsequently cytokine
production. Thereafter, circulating T cells that encounter
endothelial cells bearing foreign class I MHC molecules pro-
duce cytokines that in turn modulate MHC antigen expres-
sion of endothelial cells and macrophage activation. A sub-
set of increased activated T lymphocytes infiltrates to the
endothelial cells and induces an inflammatory response to
the endothelial cells in the early period of development of
arteiosclerotic lesions. Therefore, the infiltration-associated
inflammatory cell subsets induce activation and adherence
of macrophages, further accelerating the infiltration to the
allograft tissues (16). We also observed a large number of
inflammatory cells adherent to the endothelium as well as
adventitia. In the earlier stage of intimal proliferation, clus-
ters of subendothelial lymphocytes were seen. In the vicinity
of the endothelial lesion, inflammatory cells were recruited
and accumulated in the subendothelial space. A mild to mo-
derate degree of adventitial inflammatory cell infiltration
was observed even on day 7. This advantitial lymphocytes
were commonly seen in epicardial vessels and macrophages
interspersed among them (17).
We analysed the expression pattern of NF- B as a tran-
scription mediator that activates T lymphocyte to secrete
cytokines (IFN- , TNF- ). The high level of NF- B expres-
sion was observed in the immune cells within the coronary
arteries in the early period (Fig. 5, 6A),  concomitantly with
a high level of class I MHC antigen expression (Fig. 8).
These data might suggest the synergistic induction of cyto-
kines by NF- B and class I MHC antigen in activated im-
mune cells, a distinctive interrelation between these two
molecules. Furthermore, we confirmed in a sequential man-
ner that the expression of cytokines (IFN- , TNF- ) in the
inflammatory cells and of NF- B was upregulated in the
lesion. These inflammatory stimuli of TNF- was observed
as a high level of its expression primarily in serum in the
early stage of post-transplantation (Fig. 2A), and its expres-
sion in donor tissues was significantly increased from day 5
and on (Fig. 1A). These patterns show a temporal and spa-
tial correlation between TNF- stimulation and activated
NF- B expression. IFN- was released from the activated
immune and endothelial cells, and its expression was visual-
ized at a similarly low level in the serum and tissues in early
post-transplantation period, and then gradually increased,
and remained elevated until day 42 (Fig. 1B). However, the
level of TNF- was significantly high in the serum during
day 3-5, and showed a continuous increase therafter. The
localization of TNF- expression was observed similar to
that of the strong NF- B-positive cells. We also found a
strong correlation between the activated NF- B-modulated
immune system and the cytokines (IFN- , TNF- ) expres-
sion as a markers of inflammatory response. 
Although the pathogenesis of AGAS is not clearly under-
stood yet, our data indicate that T cell activation within the
vascular lesion can cause a local production of cytokines or
growth factors, which subsequently results in an accumulation
and proliferation of intima and smooth muscle cells of graft
arteries. Then, the intimal thickening, smooth muscle cell
proliferation, and migration into the intima, which are col-
lectively the major natures of  -actin-positive smooth mus-
cle cells, progress in donor coronary arteries and ultimately
develop the arteiosclerotic lesion (18). In addition, the cyto-
kines and growth factors that regulate migration and prolif-
eration of these smooth muscle cells were secreted from the
injured intima and released from infiltrating inflammatory
cells. The early stages of transplant arteriosclerosis may in-
volve the immune responses directed to the graft endotheli-
um, which may stimulate intimal and smooth muscle cellExpression of NF- B and Cytokines in Transplanted Murine Heart 405
proliferation in response to repeated endothelial injury (4, 16).
In the present study, we have sequentially examined a
time-dependent interrelation between the expression of cyto-
kines as NF- B targets and that of transcription factor
NF- B as a regulator of cytokines production in the coro-
nary arteries to characterize the evolution of AGAS lesions.
The immune cells and cytokines in these heterotopic car-
diac transplant have relevance to development of allograft
vasculopathy (16), and the alloantigens-expressed class I
MHC antigen induce activation and proliferation of cytoly-
tic T cell (CTLs, CD8+). Activated NF- B was found in the
thickened intima/media, in the myocardial lesion, and in
both T cells and macrophages (Fig. 5, 6). These observa-
tions suggest that transcription factors, perhaps in associa-
tion with cytokine secretion by infiltrating T lymphocytes,
play an important role in the development of the arterioscle-
rotic lesions. The cytokines secreted by these activated CD8+
lymphocytes promote the adhesion of MHC-restricted T
cells to antigen-presenting cells (APCs) or to target cells by
virtue of their specific affinity toward MHC molecules, and
participate in the early signal transduction events that occur
upon T cell recognition of peptide-MHC complexes on APCs.
Activated endothelial cells and infiltrating mononuclear
cells secrete growth factors, which promote the proliferation
of smooth muscle cells, and ultimately lead to an intimal
thickening. As shown in Fig. 4, the data suggest that colo-
calization of a high-frequency  donor class I MHC antigen
and cytokines (IFN- , TNF- ) expression might play a trig-
gering role in the intimal thickening during the develop-
ment of AGAS. Antigen presentation and IL-1 production
by macrophages result in activation and proliferation of T-
helper cells, and subsequently the release of IL-2 and other
cytokines by the activated T-helper cells results in the recruit-
ment, activation, and proliferation of cytotoxic T cells, sup-
pressor T cells, natural killer cells, and B cells. T-helper cells
may play an important role in immune-mediated vascular
pathology because they can be activated by MHC class I anti-
gens expressed on the vascular endothelial cells and smooth
muscle cells. Activated T-cells can also produce cytokines
(IFN- , TNF- ), which stimulate expression of adhesion
molecules, resulting in further recruitment of immune cells
to the vascular endothelium. The secretion of a variety of
cytokines (IFN- , TNF- , and IL-6) was induced by the
activated cytolytic T cells (CD8+) (19), and in particular,
increased IFN- further accelerates activation of macrophages
(2, 20). In addition, IFN- activates macrophages, which in
turn release an increased quantities of growth factors. Fig. 3
shows the time-dependent analysis of IFN- expression in
arteries and myocardium during the development of AGAS.
IFN- , a cytokine produced by certain T cells subset and
natural killer cells, would presumably play an initiative role
in this sequence by directly activating macrophages and by
enhancing the expressions of MHC products, other compo-
nents of the antigen presentation pathway, and adhesion
molecules. Also, the cytokines can be activated by the upre-
gulation of transcription factors, such as NF- B. VCAM-1
and ICAM-1 expression induces an infiltration of inflam-
matory cells to target cells on the vascular endothelium, and
further activates class I and II MHC antigens expression (12). 
For the infiltration of these inflammatory cells into a tar-
get site and for the release cytokines by these infiltrating cells,
recent evidence suggests that transcription factor NF- B, a
pleiotropic regulator that can modulate a numerous genes,
is related to the expression of adhesion molecules in activated
endothelium and to cytokine (IFN- , TNF- ) production
involved in immune or inflammatory response. Inflammatory
mediators, including LPS, IFN- , IL-1, and TNF- , strongly
induce ICAM-1 in a variety of tissues and greatly increase
the binding of lymphocytes and monocytes. Activated endo-
thelial cells vary as to which cytokines are capable of induc-
ing ICAM-1 expression, and the type of mediators released
may therefore help regulate different patterns of cell local-
ization induced by inflammatory stimuli. The production
of inflammatory mediators (primarily of IFN- , TNF- ) by
lymphocytes and macrophages plays an important role in
increasing the ability of endothelial cells to express leukocyte-
specific adhesion molecules, to secrete inflammatory cyto-
kines, and to facilitate the extravascular movement of inflam-
matory cells. Therefore, the present study shows that the
increase of cytokines (IFN- , TNF- ) is related with the
development of AGAS on day 7. In our recent model, vas-
cular adhesion molecules, such as ICAM-1 and VCAM-1,
were shown regulate the adhesion of leukocytes to vascular
endothelium, leading to a migration of cells into the target
tissue and play an important role in the graft rejection. The
ICAM-1 and VCAM-1 expressions in post-transplant donor
heart were increased in the very early stage and remained
elevated throughout the study. ICAM-1 and VCAM-1 expres-
sions in epicardial coronary endothelium were peaked on day
7 and 5, respectively, and remained unchanged until day
42. However, very low expressions thereof were noted in the
recipient’s coronary artery (17). The subsequent release of
cytokines enhances adhesion and migration of inflammatory
cells through endothelial cells into the tissue. The cytokines
within the lesion cause upregulation of class I MHC antigen
and vascular adhesion molecules, which make the endothe-
lium a target for cytotoxic damage by T cell (CD8+) activa-
tion. The patterns of transcription factor activation and
ICAM-1 and VCAM-1 expression were immediately seen
adjacent to the advanced lesion. These suggest that the
localized activation of the NF- B system in the AGAS
induces the expression of a leukocyte adhesion molecule.
We have shown that the patterns of cytokine (IFN- ,
TNF- ) expressions induced by the upregulation of NF- B
and of adhesion molecule expression were somewhat similar
in the lesions. These observations suggest that the activated
transcription factor NF- B modulates both adhesion
molecule and cytokines (IFN- , TNF- ) expression, and406 J.R. Lee, C.J. Seok, J.S. Kim, et al.
conversely NF- B is stimulated by the cytokines (IFN- ,
TNF- ) released from the CTLs cells. These findings provide
a correlative implication between the temporal and spatial
patterns of expression of the NF- B/I- B regulatory system
and two  B-dependent cell adhe-sion molecule genes in the
development of AGAS. In addition, these results presum-
ably provide an indirect evidence for the inflammatory
response caused by MHC disparity in the AGAS lesion, and
therefore suggest the need for blocking this system in le-
sions with less advanced arteriosclerosis. Therefore, under-
standing of the function of NF- B would be fundamental to
the study of cytokines and cytokine-mediated inflammation,
and may provide a novel therapeutic strategies for the treat-
ment and prevention of various inflammatory diseases (21,
22). To minimize the inflammatory response associated with
organ xenograft rejection, it seems mandatory to inhibit
NF- B that has been shown to play a pivotal role in the
induction of the proinflammatory genes associated with
endothelial cell activation (23).
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